Marked immunosuppression with minimal myelosuppression by bleomycin in vitro.
D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D001761:Bleomycin / Q000494:pharmacology; D001853:Bone Marrow / Q000187:drug effects*; D001854:Bone Marrow Cells; D004305:Dose-Response Relationship, Drug; D005472:Fluorouracil / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D037102:Lectins / Q000037:antagonists & inhibitors; D008213:Lymphocyte Activation / Q000187:drug effects*; D008214:Lymphocytes / Q000187:drug effects*; D008934:Mitogens / Q000037:antagonists & inhibitors; D014316:Tritium
D000903:Antibiotics, Antineoplastic; D037102:Lectins; D008934:Mitogens; D014316:Tritium; D001761:Bleomycin; D005472:Fluorouracil